China's healthcare industry, which saw record capital-raising and investment in China in 2007, has remained remarkably active this year despite the financial volatility, with many new ventures and product launches, and continued M&A and consolidation across the sector. 

 

This activity coincides with government moves to encourage R&D and innovation as well as sweeping proposals to reform healthcare policy and provide medical insurance to 90 per cent of Chinas population within two years. This combination of regulatory backing and an expanding market appears to provide venture capital, private equity and investment banks with the kinds of opportunities difficult to find elsewhere.

 

One of the fastest-growing areas of growth within this vibrant industry is the market for amino acids and other health supplements amid changing lifestyles, evolving trends in consumer health and expanding demand for products that offer a solution to both short-term and long-term health issues. Can growth continue at a rapid rate or will the financial crisis eventually take its toll?

 

This high-level Financial Times Executive Business Forum brings together leading entrepreneurs and investors involved in the consumer health industry for an informative and stimulating discussion of prospects and challenges in this fascinating area.